Back
Smith & Nephew PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
23
SNN
Smith & Nephew PLC
Last Price:
24.65
Seasonality Move:
6.39%
Sell
15
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.59
Seasonality Move:
35.83%
Sell
23
Smith & Nephew PLC (SNN)
is a Sell
Is Smith & Nephew PLC a Buy, Sell or Hold?
- The current Smith & Nephew PLC [SNN] share price is $24.62. The Score for SNN is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- SNN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.77. The Score for ADAP is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SNN Stock Price Chart
What is Smith & Nephew PLC's stock price today?
-
The Smith & Nephew PLC share price today is $24.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNN is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
SNN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.38 | Sell |
| Relative Strength Index (14 RSI): | 28.7 | Sell |
| Chaikin Money Flow: | 136940 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.27 - 29.33) | Sell |
| Bollinger Bands (100): | (26.67 - 31.01) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 41.2 | Sell |
| Chaikin Money Flow: | -836750 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.74 - 0.86) | Sell |
| Bollinger Bands (100): | (0.85 - 1.21) | Sell |
SNN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.78 | Sell |
| 20-day SMA: | 26.97 | Sell |
| 50-day SMA: | 29.03 | Sell |
| 200-day SMA: | 27.42 | Sell |
| 8-day EMA: | 25.04 | Sell |
| 20-day EMA: | 26.43 | Sell |
| 50-day EMA: | 27.98 | Sell |
| 200-day EMA: | 27.85 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.8 | Sell |
| 20-day SMA: | 0.79 | Sell |
| 50-day SMA: | 0.91 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.79 | Sell |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 0.89 | Sell |
| 200-day EMA: | 1.02 | Sell |
Smith & Nephew PLC Earnings Growth & SNN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.30 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Smith & Nephew PLC Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||